1Schur PH. Genetics of systemic lupus erythematosus. Lupus, 1995, 4:425.
2Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology, 1998, 199:265.
3Salmon JE, millard S, Schachter LA, et al. Fc gamma R Ⅱ A alleles are heritable risk factors for lupus nephritis in African Americans. J Clin lnvest, 1996, 97:1348.
4Zuniga R, Ng S, Peterson MG, et al. Low-binding alleles of Fcgama receptor types Ⅱ A and Ⅲ A are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum, 2001, 44:361.
5Tsao BP. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep, 2002, 4:359.
6Sanchez-Guerrero J, Liang MH, Karlson EW, et al. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med, 1995, 122:430.
7Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus, 2001, 10:222.
8Ehrenstein MR, Katz DR, Griffiths MH, et al. Human IgG ant-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice.Kidney Int, 1995, 48:705.
9Bootsma H, Spronk P, Derksen R,et al. Prevention of relapses in systemic lupus erythematosus. Lancet,1995,24:1595.
10Foster MH, Cizman B, Madaio MP. Nephritogenic autoantibodies in systemic lupus erythematesus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest, 1993, 69:494.
